Form 4: Alignment Healthcare Director Sells Shares for Tax Obligations

Alignment Healthcare Director Joseph S. Konowiecki sold 4,832 shares of common stock at $16.49 per share to cover tax withholding obligations related to restricted stock unit vesting.

Summary

• Director Joseph S. Konowiecki of Alignment Healthcare, Inc. (ALHC) reported a transaction involving the sale of common stock.
• On November 11, 2025, Konowiecki sold 4,832 shares of common stock.
• The shares were sold at a price of $16.49 per share.
• This sale was explicitly stated as non-discretionary, executed solely to cover tax withholding obligations arising from the vesting of restricted stock units.
• Following this transaction, Konowiecki beneficially owns 1,081,141 shares of common stock.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged trading strategy.

Sentiment

Score: 5

Explanation: The transaction is a non-discretionary sale of shares to cover tax withholding obligations related to restricted stock unit vesting, which is a routine event and does not reflect a change in the reporting person's sentiment towards the company.

Positives

• The sale was non-discretionary, executed solely to cover tax withholding obligations related to restricted stock unit vesting, rather than a voluntary decision to reduce holdings, which typically signals no change in confidence.

Negatives

• No direct negatives related to company performance or outlook are indicated by this tax-related sale.

Risks

• NA

Future Outlook

NA

Management Comments

• Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units.
• This transaction does not represent a discretionary trade by the reporting person.

Industry Context

This Form 4 reports an insider transaction, which is a routine disclosure for publicly traded companies. Such transactions, especially non-discretionary tax-related sales, are common across industries when executives' restricted stock units vest as part of their compensation packages.

Comparison to Industry Standards

• NA

Corporate Governance

Legal Proceedings

• NA

Related Party Transactions

• NA

Stakeholder Impact

• Shareholders: The sale of a relatively small number of shares for tax purposes by a director is unlikely to have a significant direct impact on the company's stock price or long-term shareholder value, especially given its non-discretionary nature.
• Employees/Management: This is a standard compensation-related event for executives, reflecting the vesting of equity awards.

Next Steps

• NA

Key Dates

Recommendation

This Form 4 reports a routine, non-discretionary sale of shares by a director to cover tax obligations associated with restricted stock unit vesting. Such a transaction does not reflect a change in the director's confidence in the company's future prospects or operational performance. Therefore, it provides no new fundamental information that would warrant a change in investment recommendation. Investors should continue to hold based on broader company fundamentals and market conditions.

Keywords

Alignment Healthcare, ALHC, Joseph S. Konowiecki, Form 4, Insider Trading, Stock Sale, Tax Withholding, Restricted Stock Units, Director Transaction, 10b5-1 Plan